25 XP   0   0   10

Shanghai Fosun Pharmaceutical Group Co Ltd
Buy, Hold or Sell?

Let's analyse Shanghai Fosun Pharmaceutical Group Co Ltd together

PenkeI guess you are interested in Shanghai Fosun Pharmaceutical Group Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Shanghai Fosun Pharmaceutical Group Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Shanghai Fosun Pharmaceutical Group Co Ltd

I send you an email if I find something interesting about Shanghai Fosun Pharmaceutical Group Co Ltd.

Quick analysis of Shanghai Fosun Pharmaceutical Group Co Ltd (30 sec.)










What can you expect buying and holding a share of Shanghai Fosun Pharmaceutical Group Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.12
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥20.95
Expected worth in 1 year
¥21.96
How sure are you?
92.5%

+ What do you gain per year?

Total Gains per Share
¥1.89
Return On Investment
8.2%

For what price can you sell your share?

Current Price per Share
¥23.13
Expected price per share
¥20.38 - ¥25.89
How sure are you?
50%

1. Valuation of Shanghai Fosun Pharmaceutical Group Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥23.13

Intrinsic Value Per Share

¥-9.30 - ¥-4.23

Total Value Per Share

¥11.64 - ¥16.71

2. Growth of Shanghai Fosun Pharmaceutical Group Co Ltd (5 min.)




Is Shanghai Fosun Pharmaceutical Group Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$7.7b$6.8b$812.8m10.6%

How much money is Shanghai Fosun Pharmaceutical Group Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$123.1m$125.4m-$2.2m-1.8%
Net Profit Margin8.1%8.2%--

How much money comes from the company's main activities?

3. Financial Health of Shanghai Fosun Pharmaceutical Group Co Ltd (5 min.)




What can you expect buying and holding a share of Shanghai Fosun Pharmaceutical Group Co Ltd? (5 min.)

Welcome investor! Shanghai Fosun Pharmaceutical Group Co Ltd's management wants to use your money to grow the business. In return you get a share of Shanghai Fosun Pharmaceutical Group Co Ltd.

What can you expect buying and holding a share of Shanghai Fosun Pharmaceutical Group Co Ltd?

First you should know what it really means to hold a share of Shanghai Fosun Pharmaceutical Group Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Shanghai Fosun Pharmaceutical Group Co Ltd is ¥23.13. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Shanghai Fosun Pharmaceutical Group Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Shanghai Fosun Pharmaceutical Group Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥20.95. Based on the TTM, the Book Value Change Per Share is ¥0.25 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.26 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.22 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Shanghai Fosun Pharmaceutical Group Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.030.1%0.040.2%0.050.2%0.050.2%0.050.2%
Usd Book Value Change Per Share0.030.1%0.030.2%0.040.2%0.060.3%0.050.2%
Usd Dividend Per Share0.080.3%0.030.1%0.030.1%0.030.1%0.040.2%
Usd Total Gains Per Share0.100.4%0.070.3%0.070.3%0.090.4%0.080.4%
Usd Price Per Share3.96-4.40-6.09-5.31-4.52-
Price to Earnings Ratio37.72-27.43-37.11-29.38-25.93-
Price-to-Total Gains Ratio38.34-77.66-138.23-137.15-84.15-
Price to Book Ratio1.37-1.54-2.33-2.21-2.34-
Price-to-Total Gains Ratio38.34-77.66-138.23-137.15-84.15-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.201192
Number of shares312
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.030.03
Usd Book Value Change Per Share0.030.06
Usd Total Gains Per Share0.070.09
Gains per Quarter (312 shares)20.4127.09
Gains per Year (312 shares)81.65108.35
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1384472347498
2768715469148206
3114131236103222314
4152174318137296422
5190218400172370530
6228262482206444638
7266305564240518746
8304349646275592854
9342392728309666962
103804368103437401070

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%86.00.01.098.9%
Book Value Change Per Share4.00.00.0100.0%9.03.00.075.0%16.04.00.080.0%32.08.00.080.0%75.012.00.086.2%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%67.00.020.077.0%
Total Gains per Share4.00.00.0100.0%11.01.00.091.7%19.01.00.095.0%37.03.00.092.5%83.04.00.095.4%

Fundamentals of Shanghai Fosun Pharmaceutical Group Co Ltd

About Shanghai Fosun Pharmaceutical Group Co Ltd

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, anti-infection, API's and intermediate, metabolism, alimentary system, cardiovascular and central nervous system. It also provides medical devices and diagnostic products. In addition, the company offers health care and hospital management services, and investment management services. Further, it engages in retail and wholesale distribution of medicines. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.

Fundamental data was last updated by Penke on 2024-03-26 15:39:07.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Shanghai Fosun Pharmaceutical Group Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Shanghai Fosun Pharmaceutical Group Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Shanghai Fosun Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 5.4% means that ¥0.05 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Shanghai Fosun Pharmaceutical Group Co Ltd:

  • The MRQ is 5.4%. The company is making a profit. +1
  • The TTM is 8.1%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ5.4%TTM8.1%-2.7%
TTM8.1%YOY8.2%-0.2%
TTM8.1%5Y10.4%-2.3%
5Y10.4%10Y14.0%-3.6%
1.1.2. Return on Assets

Shows how efficient Shanghai Fosun Pharmaceutical Group Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Shanghai Fosun Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.5% Return on Assets means that Shanghai Fosun Pharmaceutical Group Co Ltd generated ¥0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Shanghai Fosun Pharmaceutical Group Co Ltd:

  • The MRQ is 0.5%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.8%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.5%TTM0.8%-0.4%
TTM0.8%YOY0.9%-0.1%
TTM0.8%5Y1.0%-0.2%
5Y1.0%10Y1.3%-0.3%
1.1.3. Return on Equity

Shows how efficient Shanghai Fosun Pharmaceutical Group Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Shanghai Fosun Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.1% Return on Equity means Shanghai Fosun Pharmaceutical Group Co Ltd generated ¥0.01 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Shanghai Fosun Pharmaceutical Group Co Ltd:

  • The MRQ is 1.1%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.0%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.1%TTM2.0%-0.9%
TTM2.0%YOY2.3%-0.3%
TTM2.0%5Y2.5%-0.5%
5Y2.5%10Y2.9%-0.4%

1.2. Operating Efficiency of Shanghai Fosun Pharmaceutical Group Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Shanghai Fosun Pharmaceutical Group Co Ltd is operating .

  • Measures how much profit Shanghai Fosun Pharmaceutical Group Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Shanghai Fosun Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.1% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Shanghai Fosun Pharmaceutical Group Co Ltd:

  • The MRQ is 0.1%. The company is operating inefficient. -1
  • The TTM is 2.0%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ0.1%TTM2.0%-1.9%
TTM2.0%YOY7.4%-5.4%
TTM2.0%5Y9.5%-7.5%
5Y9.5%10Y5.1%+4.3%
1.2.2. Operating Ratio

Measures how efficient Shanghai Fosun Pharmaceutical Group Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.55 means that the operating costs are ¥1.55 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Shanghai Fosun Pharmaceutical Group Co Ltd:

  • The MRQ is 1.550. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.463. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.550TTM1.463+0.087
TTM1.463YOY1.467-0.003
TTM1.4635Y1.398+0.065
5Y1.39810Y0.966+0.431

1.3. Liquidity of Shanghai Fosun Pharmaceutical Group Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Shanghai Fosun Pharmaceutical Group Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.01 means the company has ¥1.01 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Shanghai Fosun Pharmaceutical Group Co Ltd:

  • The MRQ is 1.012. The company is just able to pay all its short-term debts.
  • The TTM is 1.039. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.012TTM1.039-0.027
TTM1.039YOY1.043-0.004
TTM1.0395Y1.065-0.026
5Y1.06510Y0.574+0.490
1.3.2. Quick Ratio

Measures if Shanghai Fosun Pharmaceutical Group Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Shanghai Fosun Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.34 means the company can pay off ¥0.34 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Shanghai Fosun Pharmaceutical Group Co Ltd:

  • The MRQ is 0.344. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.307. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.344TTM0.307+0.037
TTM0.307YOY0.357-0.050
TTM0.3075Y0.325-0.018
5Y0.32510Y0.299+0.025

1.4. Solvency of Shanghai Fosun Pharmaceutical Group Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Shanghai Fosun Pharmaceutical Group Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Shanghai Fosun Pharmaceutical Group Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.49 means that Shanghai Fosun Pharmaceutical Group Co Ltd assets are financed with 49.5% credit (debt) and the remaining percentage (100% - 49.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Shanghai Fosun Pharmaceutical Group Co Ltd:

  • The MRQ is 0.495. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.496. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.495TTM0.496-0.001
TTM0.496YOY0.497-0.002
TTM0.4965Y0.495+0.001
5Y0.49510Y0.479+0.016
1.4.2. Debt to Equity Ratio

Measures if Shanghai Fosun Pharmaceutical Group Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Shanghai Fosun Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 119.3% means that company has ¥1.19 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Shanghai Fosun Pharmaceutical Group Co Ltd:

  • The MRQ is 1.193. The company is able to pay all its debts with equity. +1
  • The TTM is 1.196. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.193TTM1.196-0.003
TTM1.196YOY1.227-0.032
TTM1.1965Y1.203-0.007
5Y1.20310Y1.102+0.101

2. Market Valuation of Shanghai Fosun Pharmaceutical Group Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Shanghai Fosun Pharmaceutical Group Co Ltd generates.

  • Above 15 is considered overpriced but always compare Shanghai Fosun Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 37.72 means the investor is paying ¥37.72 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Shanghai Fosun Pharmaceutical Group Co Ltd:

  • The EOD is 30.502. Based on the earnings, the company is overpriced. -1
  • The MRQ is 37.716. Based on the earnings, the company is overpriced. -1
  • The TTM is 27.429. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD30.502MRQ37.716-7.214
MRQ37.716TTM27.429+10.287
TTM27.429YOY37.115-9.686
TTM27.4295Y29.379-1.950
5Y29.37910Y25.930+3.448
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Shanghai Fosun Pharmaceutical Group Co Ltd:

  • The EOD is -24.794. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -30.657. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -47.180. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-24.794MRQ-30.657+5.863
MRQ-30.657TTM-47.180+16.523
TTM-47.180YOY-87.310+40.129
TTM-47.1805Y-48.609+1.429
5Y-48.60910Y1,228.882-1,277.491
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Shanghai Fosun Pharmaceutical Group Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Shanghai Fosun Pharmaceutical Group Co Ltd:

  • The EOD is 1.104. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.365. Based on the equity, the company is underpriced. +1
  • The TTM is 1.542. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.104MRQ1.365-0.261
MRQ1.365TTM1.542-0.176
TTM1.542YOY2.326-0.784
TTM1.5425Y2.207-0.665
5Y2.20710Y2.339-0.132
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Shanghai Fosun Pharmaceutical Group Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1970.252-22%0.263-25%0.429-54%0.329-40%
Book Value Per Share--20.94720.637+2%19.018+10%17.440+20%14.120+48%
Current Ratio--1.0121.039-3%1.043-3%1.065-5%0.574+76%
Debt To Asset Ratio--0.4950.4960%0.497-1%0.4950%0.479+3%
Debt To Equity Ratio--1.1931.1960%1.227-3%1.203-1%1.102+8%
Dividend Per Share--0.5490.220+149%0.223+147%0.199+176%0.259+112%
Eps--0.1900.315-40%0.350-46%0.351-46%0.329-42%
Free Cash Flow Per Share---0.233-0.199-15%-0.177-24%-0.134-43%-0.053-77%
Free Cash Flow To Equity Per Share---0.905-0.206-77%0.286-416%0.032-2913%0.502-280%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---4.234--------
Intrinsic Value_10Y_min---9.305--------
Intrinsic Value_1Y_max---0.243--------
Intrinsic Value_1Y_min---0.744--------
Intrinsic Value_3Y_max---0.867--------
Intrinsic Value_3Y_min---2.412--------
Intrinsic Value_5Y_max---1.659--------
Intrinsic Value_5Y_min---4.261--------
Market Cap49046240540.160-56%76434306834.60084930474429.108-10%113505209770.840-33%99149824625.557-23%78965461810.269-3%
Net Profit Margin--0.0540.081-33%0.082-34%0.104-48%0.140-61%
Operating Margin--0.0010.020-97%0.074-99%0.095-99%0.051-99%
Operating Ratio--1.5501.463+6%1.467+6%1.398+11%0.966+60%
Pb Ratio1.104-24%1.3651.542-11%2.326-41%2.207-38%2.339-42%
Pe Ratio30.502-24%37.71627.429+38%37.115+2%29.379+28%25.930+45%
Price Per Share23.130-24%28.60031.783-10%43.980-35%38.365-25%32.682-12%
Price To Free Cash Flow Ratio-24.794+19%-30.657-47.180+54%-87.310+185%-48.609+59%1228.882-102%
Price To Total Gains Ratio31.003-24%38.33577.659-51%138.231-72%137.154-72%84.145-54%
Quick Ratio--0.3440.307+12%0.357-4%0.325+6%0.299+15%
Return On Assets--0.0050.008-44%0.009-51%0.010-56%0.013-65%
Return On Equity--0.0110.020-44%0.023-52%0.025-56%0.029-62%
Total Gains Per Share--0.7460.473+58%0.485+54%0.627+19%0.589+27%
Usd Book Value--7747958590.0447632341268.212+2%6819540123.148+14%6261150482.592+24%4752743274.284+63%
Usd Book Value Change Per Share--0.0270.035-22%0.036-25%0.059-54%0.046-40%
Usd Book Value Per Share--2.8992.856+2%2.632+10%2.414+20%1.954+48%
Usd Dividend Per Share--0.0760.030+149%0.031+147%0.028+176%0.036+112%
Usd Eps--0.0260.044-40%0.048-46%0.049-46%0.045-42%
Usd Free Cash Flow---86265063.157-73520702.067-15%-63674767.911-26%-48168277.270-44%-20136731.490-77%
Usd Free Cash Flow Per Share---0.032-0.028-15%-0.025-24%-0.019-43%-0.007-77%
Usd Free Cash Flow To Equity Per Share---0.125-0.028-77%0.040-416%0.004-2913%0.069-280%
Usd Market Cap6787999690.758-56%10578508065.90911754377660.989-10%15709121032.284-33%13722335728.177-23%10928819914.541-3%
Usd Price Per Share3.201-24%3.9584.399-10%6.087-35%5.310-25%4.523-12%
Usd Profit--69974218.031123158821.390-43%125421656.684-44%126963605.071-45%109222621.507-36%
Usd Revenue--1287801824.3121489239174.826-14%1507413973.964-15%1240927439.818+4%893303497.699+44%
Usd Total Gains Per Share--0.1030.065+58%0.067+54%0.087+19%0.081+27%
 EOD+3 -5MRQTTM+12 -23YOY+11 -245Y+13 -2210Y+13 -22

3.2. Fundamental Score

Let's check the fundamental score of Shanghai Fosun Pharmaceutical Group Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1530.502
Price to Book Ratio (EOD)Between0-11.104
Net Profit Margin (MRQ)Greater than00.054
Operating Margin (MRQ)Greater than00.001
Quick Ratio (MRQ)Greater than10.344
Current Ratio (MRQ)Greater than11.012
Debt to Asset Ratio (MRQ)Less than10.495
Debt to Equity Ratio (MRQ)Less than11.193
Return on Equity (MRQ)Greater than0.150.011
Return on Assets (MRQ)Greater than0.050.005
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Shanghai Fosun Pharmaceutical Group Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.441
Ma 20Greater thanMa 5024.489
Ma 50Greater thanMa 10023.787
Ma 100Greater thanMa 20025.240
OpenGreater thanClose22.800
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-09-302022-12-312023-03-312023-06-302023-09-30
Operating Income  689,720111,270800,990295,2121,096,202-676,351419,851-460,196-40,345



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets110,767,244
Total Liabilities54,784,885
Total Stockholder Equity45,919,376
 As reported
Total Liabilities 54,784,885
Total Stockholder Equity+ 45,919,376
Total Assets = 110,767,244

Assets

Total Assets110,767,244
Total Current Assets34,914,165
Long-term Assets75,853,080
Total Current Assets
Cash And Cash Equivalents 13,047,681
Short-term Investments 2,759,221
Net Receivables 9,119,422
Inventory 7,961,906
Other Current Assets 2,025,935
Total Current Assets  (as reported)34,914,165
Total Current Assets  (calculated)34,914,165
+/- 0
Long-term Assets
Property Plant Equipment 20,052,285
Goodwill 11,004,155
Intangible Assets 16,624,401
Other Assets 6,587,889
Long-term Assets  (as reported)75,853,080
Long-term Assets  (calculated)54,268,731
+/- 21,584,349

Liabilities & Shareholders' Equity

Total Current Liabilities34,506,298
Long-term Liabilities20,278,587
Total Stockholder Equity45,919,376
Total Current Liabilities
Short Long Term Debt 15,433,494
Accounts payable 6,259,770
Other Current Liabilities 6,279,580
Total Current Liabilities  (as reported)34,506,298
Total Current Liabilities  (calculated)27,972,844
+/- 6,533,454
Long-term Liabilities
Long term Debt 12,225,868
Capital Lease Obligations Min Short Term Debt814,838
Other Liabilities 7,237,881
Long-term Liabilities Other 3,106,239
Deferred Long Term Liability 4,059,716
Long-term Liabilities  (as reported)20,278,587
Long-term Liabilities  (calculated)27,444,543
+/- 7,165,956
Total Stockholder Equity
Common Stock2,672,528
Retained Earnings 27,364,585
Other Stockholders Equity 15,943,429
Total Stockholder Equity (as reported)45,919,376
Total Stockholder Equity (calculated)45,980,542
+/- 61,166
Other
Capital Stock2,672,528
Common Stock Shares Outstanding 2,672,528
Net Debt 14,611,680
Net Invested Capital 73,578,738
Net Tangible Assets 21,822,016
Net Working Capital 407,867
Property Plant and Equipment Gross 20,052,285



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-06-302000-12-312000-06-30
> Total Assets 
1,263,855
1,571,102
1,745,208
2,207,320
2,485,646
2,872,214
2,659,060
3,139,570
3,137,913
3,528,775
3,451,263
4,218,821
4,348,820
4,976,805
5,056,587
5,170,503
5,505,110
5,522,431
5,658,218
5,668,734
5,803,551
6,077,172
6,298,778
6,633,882
6,697,741
6,763,456
6,643,086
7,434,985
7,325,121
7,307,464
7,156,248
7,538,918
8,239,215
8,623,259
10,976,722
11,527,146
12,118,484
13,397,465
14,409,128
16,820,136
19,516,486
19,432,699
20,973,203
22,290,818
22,242,619
22,322,154
22,404,890
25,507,140
25,919,867
27,602,473
27,589,581
29,475,191
30,052,246
31,047,954
33,238,439
35,336,277
35,401,461
36,346,311
37,414,561
38,201,726
39,617,346
40,944,096
42,244,099
43,767,787
47,338,126
50,633,965
56,492,186
61,971,009
63,716,970
66,199,373
68,512,821
70,551,361
72,751,765
73,689,610
78,569,298
76,119,646
77,591,633
80,169,761
80,547,989
83,686,010
86,613,733
88,479,371
90,302,729
93,293,791
95,774,597
98,804,454
104,329,254
107,163,907
107,379,375
112,142,689
110,767,244
110,767,244112,142,689107,379,375107,163,907104,329,25498,804,45495,774,59793,293,79190,302,72988,479,37186,613,73383,686,01080,547,98980,169,76177,591,63376,119,64678,569,29873,689,61072,751,76570,551,36168,512,82166,199,37363,716,97061,971,00956,492,18650,633,96547,338,12643,767,78742,244,09940,944,09639,617,34638,201,72637,414,56136,346,31135,401,46135,336,27733,238,43931,047,95430,052,24629,475,19127,589,58127,602,47325,919,86725,507,14022,404,89022,322,15422,242,61922,290,81820,973,20319,432,69919,516,48616,820,13614,409,12813,397,46512,118,48411,527,14610,976,7228,623,2598,239,2157,538,9187,156,2487,307,4647,325,1217,434,9856,643,0866,763,4566,697,7416,633,8826,298,7786,077,1725,803,5515,668,7345,658,2185,522,4315,505,1105,170,5035,056,5874,976,8054,348,8204,218,8213,451,2633,528,7753,137,9133,139,5702,659,0602,872,2142,485,6462,207,3201,745,2081,571,1021,263,855
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,634,989
16,664,092
18,001,727
18,484,905
18,376,824
23,410,317
20,403,367
20,928,124
22,559,198
22,124,797
25,084,803
27,297,507
29,205,980
30,713,459
30,424,633
31,033,491
32,136,806
34,542,933
35,279,178
35,179,942
36,851,028
34,914,165
34,914,16536,851,02835,179,94235,279,17834,542,93332,136,80631,033,49130,424,63330,713,45929,205,98027,297,50725,084,80322,124,79722,559,19820,928,12420,403,36723,410,31718,376,82418,484,90518,001,72716,664,09217,634,989000000000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,261,934
7,415,294
8,546,522
8,238,631
7,739,777
10,307,237
9,533,268
9,757,053
9,750,416
9,049,631
9,961,802
11,127,246
10,489,133
10,119,709
10,308,157
11,734,523
12,258,061
14,867,225
16,241,313
15,473,168
14,885,382
13,047,681
13,047,68114,885,38215,473,16816,241,31314,867,22512,258,06111,734,52310,308,15710,119,70910,489,13311,127,2469,961,8029,049,6319,750,4169,757,0539,533,26810,307,2377,739,7778,238,6318,546,5227,415,2948,261,934000000000000000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
138,641
0
79,078
543,383
573,011
1,344,674
456,651
334,849
992,812
1,016,413
1,970,096
2,159,600
3,267,854
3,469,380
4,241,069
2,340,779
2,386,620
1,778,100
928,532
583,194
2,435,162
2,759,221
2,759,2212,435,162583,194928,5321,778,1002,386,6202,340,7794,241,0693,469,3803,267,8542,159,6001,970,0961,016,413992,812334,849456,6511,344,674573,011543,38379,0780138,641000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
287,160
211,570
287,597
293,573
386,424
410,395
402,475
369,992
438,504
1,067,588
505,491
525,165
571,285
658,968
712,193
520,999
641,000
617,713
668,608
573,549
689,347
657,038
647,445
742,191
876,740
670,920
645,910
671,496
659,728
672,408
822,490
802,021
824,006
866,921
804,674
788,941
1,225,890
838,865
915,407
1,277,790
1,326,938
1,321,021
1,490,177
1,584,371
1,655,381
1,888,304
1,796,352
1,667,072
1,782,696
1,958,266
2,100,670
2,054,120
2,204,394
2,147,740
2,310,630
2,190,717
2,339,648
2,580,982
2,701,203
2,168,892
2,413,418
2,447,705
2,714,356
2,496,747
3,105,828
3,045,884
3,688,836
3,889,786
4,396,813
4,411,998
4,800,686
4,397,324
4,057,747
4,411,975
4,463,035
5,240,283
5,474,381
6,168,527
6,110,408
5,793,032
6,208,678
7,654,157
7,708,771
7,537,074
8,097,496
8,802,508
8,594,952
8,783,438
7,831,490
9,833,551
9,119,422
9,119,4229,833,5517,831,4908,783,4388,594,9528,802,5088,097,4967,537,0747,708,7717,654,1576,208,6785,793,0326,110,4086,168,5275,474,3815,240,2834,463,0354,411,9754,057,7474,397,3244,800,6864,411,9984,396,8133,889,7863,688,8363,045,8843,105,8282,496,7472,714,3562,447,7052,413,4182,168,8922,701,2032,580,9822,339,6482,190,7172,310,6302,147,7402,204,3942,054,1202,100,6701,958,2661,782,6961,667,0721,796,3521,888,3041,655,3811,584,3711,490,1771,321,0211,326,9381,277,790915,407838,8651,225,890788,941804,674866,921824,006802,021822,490672,408659,728671,496645,910670,920876,740742,191647,445657,038689,347573,549668,608617,713641,000520,999712,193658,968571,285525,165505,4911,067,588438,504369,992402,475410,395386,424293,573287,597211,570287,160
       Other Current Assets 
62,951
33,638
26,295
257,641
247,715
219,593
224,953
52,458
63,930
65,984
75,428
30,471
36,869
57,395
63,182
97,875
93,343
85,407
149,931
103,440
120,005
124,261
137,786
75,304
91,165
75,185
83,887
271,147
80,956
51,945
59,778
79,002
93,504
90,700
111,868
611,528
179,265
107,447
99,363
163,136
256,061
346,064
257,966
214,899
192,181
183,122
216,202
243,648
260,769
274,682
284,177
206,542
247,608
200,754
286,428
1,139,278
204,347
160,343
140,100
302,606
274,910
356,470
241,208
462,998
339,064
460,740
458,279
826,472
700,356
938,961
752,370
1,075,287
312,710
354,665
368,971
1,232,629
1,208,920
1,085,904
1,227,859
2,197,074
2,626,165
2,309,218
3,809,685
2,866,018
3,238,387
2,545,826
2,529,698
2,443,462
478,259
1,830,067
2,025,935
2,025,9351,830,067478,2592,443,4622,529,6982,545,8263,238,3872,866,0183,809,6852,309,2182,626,1652,197,0741,227,8591,085,9041,208,9201,232,629368,971354,665312,7101,075,287752,370938,961700,356826,472458,279460,740339,064462,998241,208356,470274,910302,606140,100160,343204,3471,139,278286,428200,754247,608206,542284,177274,682260,769243,648216,202183,122192,181214,899257,966346,064256,061163,13699,363107,447179,265611,528111,86890,70093,50479,00259,77851,94580,956271,14783,88775,18591,16575,304137,786124,261120,005103,440149,93185,40793,34397,87563,18257,39536,86930,47175,42865,98463,93052,458224,953219,593247,715257,64126,29533,63862,951
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
54,266,860
55,312,786
55,158,981
55,716,278
56,663,508
57,610,563
58,423,192
58,601,207
59,316,226
59,273,391
59,589,270
62,869,158
64,741,107
66,667,648
69,786,321
71,884,729
72,199,434
75,291,661
75,853,080
75,853,08075,291,66172,199,43471,884,72969,786,32166,667,64864,741,10762,869,15859,589,27059,273,39159,316,22658,601,20758,423,19257,610,56356,663,50855,716,27855,158,98155,312,78654,266,860000000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
240,211
260,598
302,430
349,398
371,578
478,324
490,787
570,536
593,404
616,642
650,746
777,221
853,209
923,746
1,003,369
1,053,971
1,078,315
1,263,290
1,110,278
1,416,670
1,234,842
1,394,729
1,226,655
1,457,076
1,183,419
1,405,097
1,278,556
1,323,190
1,178,300
1,323,570
1,128,654
1,322,715
1,160,580
1,349,373
1,201,165
1,441,990
1,331,191
1,614,022
1,596,147
2,026,082
1,752,558
2,141,104
2,168,070
3,086,242
2,968,350
3,535,644
3,231,669
4,023,239
3,743,439
4,410,283
4,047,970
5,687,323
5,063,744
5,252,620
5,365,710
5,681,397
5,722,747
5,763,552
5,687,699
5,764,931
5,784,404
5,989,205
6,176,801
6,304,732
6,439,633
6,585,656
6,766,274
8,315,870
8,493,299
8,380,516
8,790,624
9,123,052
9,640,174
9,880,167
10,667,480
11,085,069
11,235,803
11,538,703
12,208,262
13,002,704
13,425,605
12,389,105
12,573,491
13,283,929
13,793,019
14,203,419
14,847,587
16,028,093
16,631,510
18,637,713
20,052,285
20,052,28518,637,71316,631,51016,028,09314,847,58714,203,41913,793,01913,283,92912,573,49112,389,10513,425,60513,002,70412,208,26211,538,70311,235,80311,085,06910,667,4809,880,1679,640,1749,123,0528,790,6248,380,5168,493,2998,315,8706,766,2746,585,6566,439,6336,304,7326,176,8015,989,2055,784,4045,764,9315,687,6995,763,5525,722,7475,681,3975,365,7105,252,6205,063,7445,687,3234,047,9704,410,2833,743,4394,023,2393,231,6693,535,6442,968,3503,086,2422,168,0702,141,1041,752,5582,026,0821,596,1471,614,0221,331,1911,441,9901,201,1651,349,3731,160,5801,322,7151,128,6541,323,5701,178,3001,323,1901,278,5561,405,0971,183,4191,457,0761,226,6551,394,7291,234,8421,416,6701,110,2781,263,2901,078,3151,053,9711,003,369923,746853,209777,221650,746616,642593,404570,536490,787478,324371,578349,398302,430260,598240,211
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,980,168
3,039,575
3,039,539
3,255,042
3,257,298
3,254,439
3,292,539
3,303,379
3,302,360
3,337,696
3,342,228
3,473,110
3,814,009
3,817,274
3,795,919
8,464,284
8,481,954
8,449,958
8,758,270
8,853,913
8,779,798
8,861,251
9,187,138
9,013,990
9,093,819
9,093,050
8,895,931
8,677,249
8,704,246
8,622,217
8,637,249
9,399,987
9,668,586
9,933,642
10,698,416
10,337,053
10,260,335
11,059,458
11,004,155
11,004,15511,059,45810,260,33510,337,05310,698,4169,933,6429,668,5869,399,9878,637,2498,622,2178,704,2468,677,2498,895,9319,093,0509,093,8199,013,9909,187,1388,861,2518,779,7988,853,9138,758,2708,449,9588,481,9548,464,2843,795,9193,817,2743,814,0093,473,1103,342,2283,337,6963,302,3603,303,3793,292,5393,254,4393,257,2983,255,0423,039,5393,039,5752,980,1680000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21,741,547
23,623,920
24,059,648
24,690,056
24,956,212
23,518,124
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000023,518,12424,956,21224,690,05624,059,64823,623,92021,741,547000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
29,611
48,004
35,940
39,316
42,666
65,359
71,115
97,898
105,171
109,707
123,874
114,634
179,901
186,580
190,197
178,968
182,573
27,766
190,281
33,713
196,337
25,833
196,785
27,684
286,527
23,771
242,717
24,017
215,535
22,356
251,722
21,046
249,877
26,939
255,130
25,766
214,884
35,769
426,434
203,495
833,083
260,118
2,427,405
1,224,278
3,283,497
1,205,300
3,288,536
1,209,283
3,929,079
1,858,403
5,121,721
1,810,620
5,586,349
5,703,324
5,677,443
6,077,525
6,053,793
6,060,568
6,149,856
6,326,638
6,469,212
6,535,138
6,490,174
6,553,470
7,116,777
7,352,602
7,279,928
15,712,419
15,730,203
7,238,571
7,305,388
7,151,343
9,312,565
8,056,471
10,550,446
10,966,191
10,945,259
11,152,807
11,499,994
11,498,606
11,637,054
11,500,289
11,660,050
13,433,161
14,192,877
14,379,468
15,455,932
15,925,317
15,876,644
16,629,344
16,624,401
16,624,40116,629,34415,876,64415,925,31715,455,93214,379,46814,192,87713,433,16111,660,05011,500,28911,637,05411,498,60611,499,99411,152,80710,945,25910,966,19110,550,4468,056,4719,312,5657,151,3437,305,3887,238,57115,730,20315,712,4197,279,9287,352,6027,116,7776,553,4706,490,1746,535,1386,469,2126,326,6386,149,8566,060,5686,053,7936,077,5255,677,4435,703,3245,586,3491,810,6205,121,7211,858,4033,929,0791,209,2833,288,5361,205,3003,283,4971,224,2782,427,405260,118833,083203,495426,43435,769214,88425,766255,13026,939249,87721,046251,72222,356215,53524,017242,71723,771286,52727,684196,78525,833196,33733,713190,28127,766182,573178,968190,197186,580179,901114,634123,874109,707105,17197,89871,11565,35942,66639,31635,94048,00429,611
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,247,177
4,214,299
997,548
1,273,605
1,452,705
1,300,702
12,707,730
1,083,723
1,179,926
1,807,055
1,989,070
2,013,742
2,052,608
2,414,451
2,795,067
2,956,749
2,892,019
2,827,928
1,999,674
1,999,6742,827,9282,892,0192,956,7492,795,0672,414,4512,052,6082,013,7421,989,0701,807,0551,179,9261,083,72312,707,7301,300,7021,452,7051,273,605997,5484,214,2994,247,177000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
524,603
352,609
478,925
884,681
1,123,729
1,402,060
1,156,349
1,466,175
1,442,663
1,632,156
1,505,646
2,201,913
2,094,127
2,358,663
2,325,299
2,356,697
2,581,300
2,640,254
2,713,904
2,793,689
2,853,676
2,814,653
2,896,207
2,985,345
3,057,440
2,990,670
2,826,175
3,118,626
3,002,311
3,027,904
2,826,790
3,093,008
3,622,614
3,985,105
4,431,343
4,575,116
5,034,065
5,332,209
5,898,633
7,426,886
9,587,871
9,019,314
9,761,731
10,919,991
10,630,885
10,573,767
10,520,922
10,202,492
10,293,918
11,583,479
11,106,877
11,810,677
12,179,510
13,491,966
14,853,381
16,233,275
15,420,114
16,483,774
17,483,442
17,532,077
18,298,195
19,118,053
19,632,476
18,517,461
21,367,026
23,154,394
27,261,210
32,229,555
32,834,636
35,726,879
35,489,150
36,958,648
38,321,078
39,172,237
40,617,090
36,915,432
37,996,658
40,314,054
41,064,999
37,701,728
39,623,721
41,382,898
41,898,263
44,918,227
48,014,051
51,070,367
51,102,916
53,054,998
52,331,661
56,693,775
54,784,885
54,784,88556,693,77552,331,66153,054,99851,102,91651,070,36748,014,05144,918,22741,898,26341,382,89839,623,72137,701,72841,064,99940,314,05437,996,65836,915,43240,617,09039,172,23738,321,07836,958,64835,489,15035,726,87932,834,63632,229,55527,261,21023,154,39421,367,02618,517,46119,632,47619,118,05318,298,19517,532,07717,483,44216,483,77415,420,11416,233,27514,853,38113,491,96612,179,51011,810,67711,106,87711,583,47910,293,91810,202,49210,520,92210,573,76710,630,88510,919,9919,761,7319,019,3149,587,8717,426,8865,898,6335,332,2095,034,0654,575,1164,431,3433,985,1053,622,6143,093,0082,826,7903,027,9043,002,3113,118,6262,826,1752,990,6703,057,4402,985,3452,896,2072,814,6532,853,6762,793,6892,713,9042,640,2542,581,3002,356,6972,325,2992,358,6632,094,1272,201,9131,505,6461,632,1561,442,6631,466,1751,156,3491,402,0601,123,729884,681478,925352,609524,603
   > Total Current Liabilities 
487,645
324,677
453,725
859,481
1,112,129
1,391,030
1,145,950
1,412,283
1,388,771
1,578,323
1,420,368
1,166,660
1,055,943
1,587,219
1,537,566
1,594,027
1,819,431
1,683,867
1,687,840
1,706,002
1,698,043
2,031,307
2,200,469
2,342,941
2,407,964
2,485,471
2,290,161
2,218,090
2,245,425
2,192,013
1,924,974
1,755,227
1,971,195
2,407,294
1,914,971
2,498,341
2,759,813
2,899,825
2,843,939
3,706,520
3,936,351
3,504,708
4,368,611
4,994,722
5,034,369
3,997,700
4,090,703
3,893,232
3,992,545
4,789,138
4,292,574
5,278,121
5,451,622
6,093,293
6,438,530
9,537,321
8,549,039
10,211,111
10,893,887
10,939,200
8,820,512
10,810,276
11,085,357
10,108,554
10,974,784
10,183,855
14,554,788
16,600,472
17,828,255
23,706,386
17,756,959
17,923,246
15,930,300
17,841,318
19,327,467
17,433,765
17,333,302
22,538,541
21,941,029
24,872,353
25,879,452
28,157,254
28,658,131
29,309,945
30,305,396
31,967,361
31,261,527
33,298,069
32,468,080
36,818,804
34,506,298
34,506,29836,818,80432,468,08033,298,06931,261,52731,967,36130,305,39629,309,94528,658,13128,157,25425,879,45224,872,35321,941,02922,538,54117,333,30217,433,76519,327,46717,841,31815,930,30017,923,24617,756,95923,706,38617,828,25516,600,47214,554,78810,183,85510,974,78410,108,55411,085,35710,810,2768,820,51210,939,20010,893,88710,211,1118,549,0399,537,3216,438,5306,093,2935,451,6225,278,1214,292,5744,789,1383,992,5453,893,2324,090,7033,997,7005,034,3694,994,7224,368,6113,504,7083,936,3513,706,5202,843,9392,899,8252,759,8132,498,3411,914,9712,407,2941,971,1951,755,2271,924,9742,192,0132,245,4252,218,0902,290,1612,485,4712,407,9642,342,9412,200,4692,031,3071,698,0431,706,0021,687,8401,683,8671,819,4311,594,0271,537,5661,587,2191,055,9431,166,6601,420,3681,578,3231,388,7711,412,2831,145,9501,391,0301,112,129859,481453,725324,677487,645
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,248,292
3,980,054
4,925,828
5,843,243
6,201,297
7,440,018
6,358,287
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000006,358,2877,440,0186,201,2975,843,2434,925,8283,980,0544,248,292000000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,248,292
3,980,054
4,925,828
5,843,243
6,201,297
7,440,018
6,358,287
7,274,455
7,383,127
7,702,350
7,915,983
8,554,453
7,613,928
8,842,470
9,420,129
10,720,280
13,054,957
11,829,020
11,931,537
14,012,819
16,621,172
15,433,494
15,433,49416,621,17214,012,81911,931,53711,829,02013,054,95710,720,2809,420,1298,842,4707,613,9288,554,4537,915,9837,702,3507,383,1277,274,4556,358,2877,440,0186,201,2975,843,2434,925,8283,980,0544,248,292000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
80,295
70,502
103,464
89,493
112,988
147,904
167,836
326,314
328,127
394,612
343,447
339,278
374,245
430,078
390,342
484,027
481,688
509,329
469,249
560,274
564,992
519,770
525,153
530,941
409,271
394,667
327,497
357,824
362,188
375,838
330,095
398,029
397,115
370,641
413,234
491,288
467,315
489,091
489,461
827,287
790,561
802,611
748,368
939,936
847,872
911,459
922,350
903,722
816,356
950,748
1,107,656
1,136,450
1,269,363
1,281,467
1,299,036
904,962
962,535
948,363
942,394
1,048,650
916,827
1,100,576
1,033,142
1,149,379
1,154,880
1,285,434
1,187,858
1,781,884
2,014,182
2,155,887
2,110,312
2,333,283
2,553,159
2,540,637
2,500,613
2,397,315
2,493,996
2,864,017
2,872,897
3,289,021
3,271,879
3,745,584
3,698,587
5,063,661
5,702,894
5,707,081
5,451,739
6,284,041
6,637,989
6,398,619
6,259,770
6,259,7706,398,6196,637,9896,284,0415,451,7395,707,0815,702,8945,063,6613,698,5873,745,5843,271,8793,289,0212,872,8972,864,0172,493,9962,397,3152,500,6132,540,6372,553,1592,333,2832,110,3122,155,8872,014,1821,781,8841,187,8581,285,4341,154,8801,149,3791,033,1421,100,576916,8271,048,650942,394948,363962,535904,9621,299,0361,281,4671,269,3631,136,4501,107,656950,748816,356903,722922,350911,459847,872939,936748,368802,611790,561827,287489,461489,091467,315491,288413,234370,641397,115398,029330,095375,838362,188357,824327,497394,667409,271530,941525,153519,770564,992560,274469,249509,329481,688484,027390,342430,078374,245339,278343,447394,612328,127326,314167,836147,904112,98889,493103,46470,50280,295
       Other Current Liabilities 
166,000
124,505
79,011
142,538
121,591
208,626
151,974
313,674
298,163
318,930
285,935
361,096
458,878
505,141
497,008
428,000
441,343
406,138
356,191
359,419
436,196
348,137
367,216
346,825
512,784
318,595
332,780
303,916
317,341
475,003
363,569
854,681
870,076
1,034,561
413,996
424,055
621,466
809,959
702,370
1,048,847
739,629
985,318
1,641,850
1,867,735
1,458,886
1,597,436
1,781,180
2,114,179
2,260,402
2,028,028
1,624,450
2,717,461
2,092,572
3,155,768
2,757,159
3,682,715
2,579,888
3,277,389
2,558,055
2,556,376
2,591,662
2,532,760
2,457,828
2,809,035
2,564,978
3,663,379
3,389,053
4,340,393
3,645,810
2,892,224
3,635,409
2,275,143
3,445,780
3,681,917
3,805,206
2,267,303
5,528,226
3,166,464
5,681,775
2,510,518
7,893,248
4,191,471
7,958,722
3,683,709
6,898,572
3,992,134
7,270,405
4,091,615
7,003,477
4,049,845
6,279,580
6,279,5804,049,8457,003,4774,091,6157,270,4053,992,1346,898,5723,683,7097,958,7224,191,4717,893,2482,510,5185,681,7753,166,4645,528,2262,267,3033,805,2063,681,9173,445,7802,275,1433,635,4092,892,2243,645,8104,340,3933,389,0533,663,3792,564,9782,809,0352,457,8282,532,7602,591,6622,556,3762,558,0553,277,3892,579,8883,682,7152,757,1593,155,7682,092,5722,717,4611,624,4502,028,0282,260,4022,114,1791,781,1801,597,4361,458,8861,867,7351,641,850985,318739,6291,048,847702,370809,959621,466424,055413,9961,034,561870,076854,681363,569475,003317,341303,916332,780318,595512,784346,825367,216348,137436,196359,419356,191406,138441,343428,000497,008505,141458,878361,096285,935318,930298,163313,674151,974208,626121,591142,53879,011124,505166,000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
22,390,778
21,330,919
21,289,623
19,481,667
20,663,355
17,775,512
19,123,970
12,829,375
13,744,269
13,225,644
13,240,132
15,608,281
17,708,655
19,103,006
19,841,389
19,756,928
19,863,580
19,874,972
20,278,587
20,278,58719,874,97219,863,58019,756,92819,841,38919,103,00617,708,65515,608,28113,240,13213,225,64413,744,26912,829,37519,123,97017,775,51220,663,35519,481,66721,289,62321,330,91922,390,778000000000000000000000000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-4,248,292
-3,980,054
-4,925,828
-5,515,772
-5,831,732
-7,132,805
-5,948,099
407,883
369,340
532,903
627,291
608,940
706,945
678,596
648,360
698,364
687,975
671,605
744,993
737,929
760,883
814,838
814,838760,883737,929744,993671,605687,975698,364648,360678,596706,945608,940627,291532,903369,340407,883-5,948,099-7,132,805-5,831,732-5,515,772-4,925,828-3,980,054-4,248,292000000000000000000000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,791,670
17,751,982
2,878,227
2,831,967
2,868,112
2,859,638
2,637,218
121,713
222,634
285,708
282,365
2,213,874
2,396,513
2,543,657
2,997,348
2,874,626
2,830,659
3,073,307
3,106,239
3,106,2393,073,3072,830,6592,874,6262,997,3482,543,6572,396,5132,213,874282,365285,708222,634121,7132,637,2182,859,6382,868,1122,831,9672,878,22717,751,98218,791,670000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,597,644
1,867,398
2,164,632
2,019,883
2,315,101
2,790,916
3,224,202
3,415,558
3,566,642
3,183,447
3,151,724
3,260,995
3,483,053
3,759,439
3,632,143
3,535,706
3,629,955
3,925,823
4,008,493
0
4,063,911
4,059,716
4,059,7164,063,91104,008,4933,925,8233,629,9553,535,7063,632,1433,759,4393,483,0533,260,9953,151,7243,183,4473,566,6423,415,5583,224,2022,790,9162,315,1012,019,8832,164,6321,867,3981,597,644000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
666,648
1,145,524
1,198,495
1,263,984
1,294,211
1,329,256
1,361,401
1,409,511
1,437,437
1,624,952
1,657,036
1,700,183
1,921,694
2,153,705
2,245,886
2,304,105
2,390,929
2,352,552
2,408,964
2,390,880
2,452,260
2,796,592
2,932,229
3,090,221
3,139,478
3,261,483
3,307,471
3,872,266
3,877,250
3,842,246
3,930,835
4,008,860
4,179,550
4,209,302
6,089,106
6,476,522
6,596,512
7,596,919
7,947,126
8,423,023
8,929,766
9,293,260
9,869,365
9,771,863
9,984,913
10,140,714
10,203,924
13,558,793
13,940,232
14,203,505
14,593,259
15,332,184
15,628,747
15,430,039
16,776,036
16,674,849
17,503,290
17,493,198
17,562,820
18,181,570
18,708,518
18,992,825
19,617,469
22,190,216
22,803,930
24,660,433
25,532,125
25,326,868
25,915,596
25,563,526
28,529,784
27,977,736
28,720,052
28,728,361
30,633,747
31,888,066
32,731,674
33,039,577
33,083,710
36,995,533
37,697,530
37,860,936
38,938,689
39,191,949
38,328,657
38,198,814
43,525,912
44,582,458
45,393,161
45,460,014
45,919,376
45,919,37645,460,01445,393,16144,582,45843,525,91238,198,81438,328,65739,191,94938,938,68937,860,93637,697,53036,995,53333,083,71033,039,57732,731,67431,888,06630,633,74728,728,36128,720,05227,977,73628,529,78425,563,52625,915,59625,326,86825,532,12524,660,43322,803,93022,190,21619,617,46918,992,82518,708,51818,181,57017,562,82017,493,19817,503,29016,674,84916,776,03615,430,03915,628,74715,332,18414,593,25914,203,50513,940,23213,558,79310,203,92410,140,7149,984,9139,771,8639,869,3659,293,2608,929,7668,423,0237,947,1267,596,9196,596,5126,476,5226,089,1064,209,3024,179,5504,008,8603,930,8353,842,2463,877,2503,872,2663,307,4713,261,4833,139,4783,090,2212,932,2292,796,5922,452,2602,390,8802,408,9642,352,5522,390,9292,304,1052,245,8862,153,7051,921,6941,700,1831,657,0361,624,9521,437,4371,409,5111,361,4011,329,2561,294,2111,263,9841,198,4951,145,524666,648
   Common Stock
271,260
293,760
293,760
293,760
293,760
381,888
381,888
381,888
381,888
381,888
381,888
381,888
381,888
817,825
826,461
826,461
826,463
831,949
831,960
831,961
832,003
935,602
952,135
952,135
952,135
1,237,775
1,237,775
1,237,775
1,237,775
1,237,775
1,237,775
1,237,775
1,237,775
1,237,775
1,237,775
1,237,775
1,237,775
1,269,595
1,904,392
1,904,392
1,904,392
1,904,392
1,904,392
1,904,392
1,904,392
1,904,392
1,904,392
2,240,462
2,240,462
2,240,462
2,240,462
2,240,462
2,244,397
2,311,611
2,311,611
2,311,611
2,311,380
2,311,380
2,311,380
2,314,075
2,314,075
2,314,075
2,314,075
2,414,512
2,414,475
2,495,131
2,495,131
2,495,131
2,495,131
2,495,061
2,563,061
2,563,061
2,563,061
2,562,899
2,562,899
2,562,899
2,562,899
2,562,899
2,562,899
2,562,899
2,562,899
2,562,899
2,562,899
2,562,899
2,562,899
2,562,899
2,669,655
2,672,157
0
2,672,157
2,672,528
2,672,5282,672,15702,672,1572,669,6552,562,8992,562,8992,562,8992,562,8992,562,8992,562,8992,562,8992,562,8992,562,8992,562,8992,562,8992,562,8992,562,8992,563,0612,563,0612,563,0612,495,0612,495,1312,495,1312,495,1312,495,1312,414,4752,414,5122,314,0752,314,0752,314,0752,314,0752,311,3802,311,3802,311,3802,311,6112,311,6112,311,6112,244,3972,240,4622,240,4622,240,4622,240,4622,240,4621,904,3921,904,3921,904,3921,904,3921,904,3921,904,3921,904,3921,904,3921,904,3921,269,5951,237,7751,237,7751,237,7751,237,7751,237,7751,237,7751,237,7751,237,7751,237,7751,237,7751,237,7751,237,775952,135952,135952,135935,602832,003831,961831,960831,949826,463826,461826,461817,825381,888381,888381,888381,888381,888381,888381,888381,888293,760293,760293,760293,760271,260
   Retained Earnings 
131,309
108,589
170,546
143,394
173,526
205,831
237,737
182,106
214,138
397,548
429,632
372,497
436,737
413,044
461,787
411,289
470,732
407,778
461,115
349,335
410,234
187,262
239,791
262,863
299,514
596,611
677,568
715,129
915,144
1,087,582
1,200,376
1,184,756
1,357,437
1,404,014
3,278,652
3,258,171
3,588,501
3,682,651
3,742,264
3,717,745
3,970,223
4,394,006
4,594,853
4,483,475
4,818,700
4,994,803
5,386,259
5,703,028
6,055,036
6,285,673
6,621,611
7,112,693
9,011,986
8,975,945
7,205,268
7,119,418
7,655,774
7,775,778
8,363,263
8,932,388
9,566,619
9,692,150
10,368,772
11,115,336
11,853,083
11,931,100
12,661,307
13,366,540
14,112,432
13,999,065
14,532,747
15,146,518
13,483,810
13,470,326
14,017,910
17,649,509
18,119,387
18,256,394
19,049,756
20,233,588
21,080,774
21,612,964
22,695,325
23,865,861
24,361,515
24,010,872
24,917,905
26,169,781
24,236,966
26,858,090
27,364,585
27,364,58526,858,09024,236,96626,169,78124,917,90524,010,87224,361,51523,865,86122,695,32521,612,96421,080,77420,233,58819,049,75618,256,39418,119,38717,649,50914,017,91013,470,32613,483,81015,146,51814,532,74713,999,06514,112,43213,366,54012,661,30711,931,10011,853,08311,115,33610,368,7729,692,1509,566,6198,932,3888,363,2637,775,7787,655,7747,119,4187,205,2688,975,9459,011,9867,112,6936,621,6116,285,6736,055,0365,703,0285,386,2594,994,8034,818,7004,483,4754,594,8534,394,0063,970,2233,717,7453,742,2643,682,6513,588,5013,258,1713,278,6521,404,0141,357,4371,184,7561,200,3761,087,582915,144715,129677,568596,611299,514262,863239,791187,262410,234349,335461,115407,778470,732411,289461,787413,044436,737372,497429,632397,548214,138182,106237,737205,831173,526143,394170,546108,589131,309
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000-8,784-8,784-9,523-9,523-18,767-18,767-18,767-26,819-36,062-36,062-36,062-43,49400000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-65,028
-238,209
-274,780
10,299,893
-245,976
11,679,253
-467,994
12,049,388
-414,837
11,471,055
-933,579
14,053,857
-1,030,880
-1,071,253
-1,265,832
11,404,243
-1,230,105
15,938,352
-1,198,364
0
-972,683
15,943,429
15,943,429-972,6830-1,198,36415,938,352-1,230,10511,404,243-1,265,832-1,071,253-1,030,88014,053,857-933,57911,471,055-414,83712,049,388-467,99411,679,253-245,97610,299,893-274,780-238,209-65,028000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue43,028,896
Cost of Revenue-22,036,723
Gross Profit20,992,17320,992,173
 
Operating Income (+$)
Gross Profit20,992,173
Operating Expense-40,721,909
Operating Income2,306,988-19,729,735
 
Operating Expense (+$)
Research Development4,594,551
Selling General Administrative11,430,412
Selling And Marketing Expenses-
Operating Expense40,721,90916,024,963
 
Net Interest Income (+$)
Interest Income215,244
Interest Expense-1,212,749
Other Finance Cost-89,265
Net Interest Income-1,086,770
 
Pretax Income (+$)
Operating Income2,306,988
Net Interest Income-1,086,770
Other Non-Operating Income Expenses-
Income Before Tax (EBT)4,495,7612,306,988
EBIT - interestExpense = -1,212,749
3,577,671
4,790,420
Interest Expense1,212,749
Earnings Before Interest and Taxes (EBIT)-5,708,510
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax4,495,761
Tax Provision-654,025
Net Income From Continuing Ops3,841,7363,841,736
Net Income3,577,671
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-1,086,770
 

Technical Analysis of Shanghai Fosun Pharmaceutical Group Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Shanghai Fosun Pharmaceutical Group Co Ltd. The general trend of Shanghai Fosun Pharmaceutical Group Co Ltd is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Shanghai Fosun Pharmaceutical Group Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Shanghai Fosun Pharmaceutical Group Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 24.15 < 25.79 < 25.89.

The bearish price targets are: 20.38.

Tweet this
Shanghai Fosun Pharmaceutical Group Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Shanghai Fosun Pharmaceutical Group Co Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Shanghai Fosun Pharmaceutical Group Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Shanghai Fosun Pharmaceutical Group Co Ltd. The current macd is -0.18977946.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Shanghai Fosun Pharmaceutical Group Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Shanghai Fosun Pharmaceutical Group Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Shanghai Fosun Pharmaceutical Group Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Shanghai Fosun Pharmaceutical Group Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartShanghai Fosun Pharmaceutical Group Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Shanghai Fosun Pharmaceutical Group Co Ltd. The current adx is 23.52.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Shanghai Fosun Pharmaceutical Group Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Shanghai Fosun Pharmaceutical Group Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Shanghai Fosun Pharmaceutical Group Co Ltd. The current sar is 25.31.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Shanghai Fosun Pharmaceutical Group Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Shanghai Fosun Pharmaceutical Group Co Ltd. The current rsi is 38.44. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Shanghai Fosun Pharmaceutical Group Co Ltd Daily Relative Strength Index (RSI) ChartShanghai Fosun Pharmaceutical Group Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Shanghai Fosun Pharmaceutical Group Co Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Shanghai Fosun Pharmaceutical Group Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Shanghai Fosun Pharmaceutical Group Co Ltd Daily Stochastic Oscillator ChartShanghai Fosun Pharmaceutical Group Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Shanghai Fosun Pharmaceutical Group Co Ltd. The current cci is -188.97967735.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Shanghai Fosun Pharmaceutical Group Co Ltd Daily Commodity Channel Index (CCI) ChartShanghai Fosun Pharmaceutical Group Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Shanghai Fosun Pharmaceutical Group Co Ltd. The current cmo is -34.67570124.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Shanghai Fosun Pharmaceutical Group Co Ltd Daily Chande Momentum Oscillator (CMO) ChartShanghai Fosun Pharmaceutical Group Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Shanghai Fosun Pharmaceutical Group Co Ltd. The current willr is -85.53054662.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Shanghai Fosun Pharmaceutical Group Co Ltd Daily Williams %R ChartShanghai Fosun Pharmaceutical Group Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Shanghai Fosun Pharmaceutical Group Co Ltd.

Shanghai Fosun Pharmaceutical Group Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Shanghai Fosun Pharmaceutical Group Co Ltd. The current atr is 0.57425503.

Shanghai Fosun Pharmaceutical Group Co Ltd Daily Average True Range (ATR) ChartShanghai Fosun Pharmaceutical Group Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Shanghai Fosun Pharmaceutical Group Co Ltd. The current obv is 476,052,021.

Shanghai Fosun Pharmaceutical Group Co Ltd Daily On-Balance Volume (OBV) ChartShanghai Fosun Pharmaceutical Group Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Shanghai Fosun Pharmaceutical Group Co Ltd. The current mfi is 43.66.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Shanghai Fosun Pharmaceutical Group Co Ltd Daily Money Flow Index (MFI) ChartShanghai Fosun Pharmaceutical Group Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Shanghai Fosun Pharmaceutical Group Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-03STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-11-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Shanghai Fosun Pharmaceutical Group Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Shanghai Fosun Pharmaceutical Group Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.441
Ma 20Greater thanMa 5024.489
Ma 50Greater thanMa 10023.787
Ma 100Greater thanMa 20025.240
OpenGreater thanClose22.800
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Shanghai Fosun Pharmaceutical Group Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Shanghai Fosun Pharmaceutical Group Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Shanghai Fosun Pharmaceutical Group Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Shanghai Fosun Pharmaceutical Group Co Ltd

I send you an email if I find something interesting about Shanghai Fosun Pharmaceutical Group Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Shanghai Fosun Pharmaceutical Group Co Ltd.

Receive notifications about Shanghai Fosun Pharmaceutical Group Co Ltd in your mailbox!